NO862750L - Fremgangsmaate for fremstilling av farmakologisk aktive oksindol-derivater. - Google Patents
Fremgangsmaate for fremstilling av farmakologisk aktive oksindol-derivater.Info
- Publication number
- NO862750L NO862750L NO862750A NO862750A NO862750L NO 862750 L NO862750 L NO 862750L NO 862750 A NO862750 A NO 862750A NO 862750 A NO862750 A NO 862750A NO 862750 L NO862750 L NO 862750L
- Authority
- NO
- Norway
- Prior art keywords
- carbon atoms
- mol
- added
- formula
- reaction mixture
- Prior art date
Links
- 238000000034 method Methods 0.000 title claims description 43
- 238000002360 preparation method Methods 0.000 title claims description 11
- JYGFTBXVXVMTGB-UHFFFAOYSA-N indolin-2-one Chemical class C1=CC=C2NC(=O)CC2=C1 JYGFTBXVXVMTGB-UHFFFAOYSA-N 0.000 title description 10
- 238000006243 chemical reaction Methods 0.000 claims abstract description 20
- 239000012948 isocyanate Substances 0.000 claims abstract description 14
- 150000002513 isocyanates Chemical class 0.000 claims abstract description 14
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical group CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 claims description 93
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 claims description 57
- 125000004432 carbon atom Chemical group C* 0.000 claims description 47
- 239000000460 chlorine Chemical group 0.000 claims description 19
- -1 oxindole compound Chemical class 0.000 claims description 19
- 238000010992 reflux Methods 0.000 claims description 17
- 239000002904 solvent Substances 0.000 claims description 17
- 125000000217 alkyl group Chemical group 0.000 claims description 16
- 239000001257 hydrogen Substances 0.000 claims description 16
- 229910052739 hydrogen Inorganic materials 0.000 claims description 16
- PCKPVGOLPKLUHR-UHFFFAOYSA-N OH-Indolxyl Natural products C1=CC=C2C(O)=CNC2=C1 PCKPVGOLPKLUHR-UHFFFAOYSA-N 0.000 claims description 12
- 239000002585 base Substances 0.000 claims description 12
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical group [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 claims description 10
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical group FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 claims description 10
- 125000003545 alkoxy group Chemical group 0.000 claims description 10
- 125000004414 alkyl thio group Chemical group 0.000 claims description 10
- 229910052801 chlorine Inorganic materials 0.000 claims description 10
- 239000011737 fluorine Chemical group 0.000 claims description 10
- 229910052731 fluorine Inorganic materials 0.000 claims description 10
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical group [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 claims description 9
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Chemical group BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 claims description 9
- 229910052794 bromium Inorganic materials 0.000 claims description 9
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 claims description 8
- 150000001412 amines Chemical class 0.000 claims description 8
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 8
- 125000000753 cycloalkyl group Chemical group 0.000 claims description 7
- 150000003839 salts Chemical class 0.000 claims description 7
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 claims description 6
- 125000002252 acyl group Chemical group 0.000 claims description 5
- 125000000623 heterocyclic group Chemical group 0.000 claims description 5
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 claims description 5
- SECXISVLQFMRJM-UHFFFAOYSA-N N-Methylpyrrolidone Chemical compound CN1CCCC1=O SECXISVLQFMRJM-UHFFFAOYSA-N 0.000 claims description 4
- 239000012442 inert solvent Substances 0.000 claims description 4
- CVICEEPAFUYBJG-UHFFFAOYSA-N 5-chloro-2,2-difluoro-1,3-benzodioxole Chemical group C1=C(Cl)C=C2OC(F)(F)OC2=C1 CVICEEPAFUYBJG-UHFFFAOYSA-N 0.000 claims description 3
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 claims description 3
- 229910052784 alkaline earth metal Inorganic materials 0.000 claims description 3
- 239000008096 xylene Substances 0.000 claims description 3
- SUAKHGWARZSWIH-UHFFFAOYSA-N N,N‐diethylformamide Chemical compound CCN(CC)C=O SUAKHGWARZSWIH-UHFFFAOYSA-N 0.000 claims description 2
- 150000001342 alkaline earth metals Chemical class 0.000 claims description 2
- 239000003849 aromatic solvent Substances 0.000 claims description 2
- 125000003236 benzoyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C(*)=O 0.000 claims description 2
- 125000002541 furyl group Chemical group 0.000 claims description 2
- 125000002883 imidazolyl group Chemical group 0.000 claims description 2
- 125000000842 isoxazolyl group Chemical group 0.000 claims description 2
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 claims description 2
- 125000002971 oxazolyl group Chemical group 0.000 claims description 2
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 2
- 239000003586 protic polar solvent Substances 0.000 claims description 2
- 125000004076 pyridyl group Chemical group 0.000 claims description 2
- 125000000168 pyrrolyl group Chemical group 0.000 claims description 2
- 125000000335 thiazolyl group Chemical group 0.000 claims description 2
- 125000001544 thienyl group Chemical group 0.000 claims description 2
- 125000004201 2,4-dichlorophenyl group Chemical group [H]C1=C([H])C(*)=C(Cl)C([H])=C1Cl 0.000 claims 2
- 229910000102 alkali metal hydride Inorganic materials 0.000 claims 1
- 150000008046 alkali metal hydrides Chemical class 0.000 claims 1
- 150000001875 compounds Chemical class 0.000 abstract description 30
- 239000002260 anti-inflammatory agent Substances 0.000 abstract description 6
- 239000000730 antalgic agent Substances 0.000 abstract description 4
- 238000007098 aminolysis reaction Methods 0.000 abstract description 2
- 230000003110 anti-inflammatory effect Effects 0.000 abstract description 2
- 125000005907 alkyl ester group Chemical group 0.000 abstract 1
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical group CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 100
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 88
- 239000011541 reaction mixture Substances 0.000 description 72
- 239000000243 solution Substances 0.000 description 71
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 57
- 239000007787 solid Substances 0.000 description 57
- 239000000203 mixture Substances 0.000 description 54
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 51
- 239000000047 product Substances 0.000 description 46
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 45
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 44
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 41
- 238000004519 manufacturing process Methods 0.000 description 20
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 19
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 18
- 238000003756 stirring Methods 0.000 description 17
- DGTNSSLYPYDJGL-UHFFFAOYSA-N phenyl isocyanate Chemical compound O=C=NC1=CC=CC=C1 DGTNSSLYPYDJGL-UHFFFAOYSA-N 0.000 description 16
- 238000001914 filtration Methods 0.000 description 15
- 238000001953 recrystallisation Methods 0.000 description 13
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 12
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 12
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical class [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 10
- 150000003857 carboxamides Chemical class 0.000 description 10
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 9
- 239000002244 precipitate Substances 0.000 description 9
- ADAKRBAJFHTIEW-UHFFFAOYSA-N 1-chloro-4-isocyanatobenzene Chemical compound ClC1=CC=C(N=C=O)C=C1 ADAKRBAJFHTIEW-UHFFFAOYSA-N 0.000 description 7
- 150000002431 hydrogen Chemical group 0.000 description 7
- UYINJAQCJCYCGO-UHFFFAOYSA-N 2-oxo-3h-indole-1-carboxamide Chemical class C1=CC=C2N(C(=O)N)C(=O)CC2=C1 UYINJAQCJCYCGO-UHFFFAOYSA-N 0.000 description 6
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 6
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 6
- VSCWAEJMTAWNJL-UHFFFAOYSA-K aluminium trichloride Chemical compound Cl[Al](Cl)Cl VSCWAEJMTAWNJL-UHFFFAOYSA-K 0.000 description 6
- 239000003153 chemical reaction reagent Substances 0.000 description 6
- NUJOXMJBOLGQSY-UHFFFAOYSA-N manganese dioxide Chemical compound O=[Mn]=O NUJOXMJBOLGQSY-UHFFFAOYSA-N 0.000 description 6
- 239000002808 molecular sieve Substances 0.000 description 6
- 239000012074 organic phase Substances 0.000 description 6
- 239000011734 sodium Substances 0.000 description 6
- URGAHOPLAPQHLN-UHFFFAOYSA-N sodium aluminosilicate Chemical compound [Na+].[Al+3].[O-][Si]([O-])=O.[O-][Si]([O-])=O URGAHOPLAPQHLN-UHFFFAOYSA-N 0.000 description 6
- OLBJNSPBWLCTOT-UHFFFAOYSA-N 2,4-dichloro-1-isocyanatobenzene Chemical compound ClC1=CC=C(N=C=O)C(Cl)=C1 OLBJNSPBWLCTOT-UHFFFAOYSA-N 0.000 description 5
- HSYFISNDMZKGRS-UHFFFAOYSA-N 4-chloro-1h-indole-2,3-dione Chemical compound ClC1=CC=CC2=C1C(=O)C(=O)N2 HSYFISNDMZKGRS-UHFFFAOYSA-N 0.000 description 5
- 239000002253 acid Substances 0.000 description 5
- 229940121363 anti-inflammatory agent Drugs 0.000 description 5
- 239000007864 aqueous solution Substances 0.000 description 5
- 239000000706 filtrate Substances 0.000 description 5
- NWZSZGALRFJKBT-KNIFDHDWSA-N (2s)-2,6-diaminohexanoic acid;(2s)-2-hydroxybutanedioic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O.NCCCC[C@H](N)C(O)=O NWZSZGALRFJKBT-KNIFDHDWSA-N 0.000 description 4
- RVXLBLSGEPQBIO-UHFFFAOYSA-N 6-chloro-1h-indole-2,3-dione Chemical compound ClC1=CC=C2C(=O)C(=O)NC2=C1 RVXLBLSGEPQBIO-UHFFFAOYSA-N 0.000 description 4
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 4
- 206010061218 Inflammation Diseases 0.000 description 4
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 4
- WQDUMFSSJAZKTM-UHFFFAOYSA-N Sodium methoxide Chemical compound [Na+].[O-]C WQDUMFSSJAZKTM-UHFFFAOYSA-N 0.000 description 4
- 239000004480 active ingredient Substances 0.000 description 4
- 230000015572 biosynthetic process Effects 0.000 description 4
- 239000003937 drug carrier Substances 0.000 description 4
- 238000001704 evaporation Methods 0.000 description 4
- 230000008020 evaporation Effects 0.000 description 4
- IKDUDTNKRLTJSI-UHFFFAOYSA-N hydrazine monohydrate Substances O.NN IKDUDTNKRLTJSI-UHFFFAOYSA-N 0.000 description 4
- 230000004054 inflammatory process Effects 0.000 description 4
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 4
- 150000005623 oxindoles Chemical class 0.000 description 4
- 239000012071 phase Substances 0.000 description 4
- 239000002002 slurry Substances 0.000 description 4
- 239000000725 suspension Substances 0.000 description 4
- 238000001665 trituration Methods 0.000 description 4
- BJFCCDMOVSQLQF-UHFFFAOYSA-N 1-(1h-indol-7-yl)ethanone Chemical compound CC(=O)C1=CC=CC2=C1NC=C2 BJFCCDMOVSQLQF-UHFFFAOYSA-N 0.000 description 3
- WSGYTJNNHPZFKR-UHFFFAOYSA-N 3-hydroxypropanenitrile Chemical compound OCCC#N WSGYTJNNHPZFKR-UHFFFAOYSA-N 0.000 description 3
- WFDIJRYMOXRFFG-UHFFFAOYSA-N Acetic anhydride Chemical compound CC(=O)OC(C)=O WFDIJRYMOXRFFG-UHFFFAOYSA-N 0.000 description 3
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical class [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 3
- QGJOPFRUJISHPQ-UHFFFAOYSA-N Carbon disulfide Chemical compound S=C=S QGJOPFRUJISHPQ-UHFFFAOYSA-N 0.000 description 3
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 3
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 3
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical class [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 3
- 230000009102 absorption Effects 0.000 description 3
- 238000010521 absorption reaction Methods 0.000 description 3
- 238000004587 chromatography analysis Methods 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- OAYLNYINCPYISS-UHFFFAOYSA-N ethyl acetate;hexane Chemical compound CCCCCC.CCOC(C)=O OAYLNYINCPYISS-UHFFFAOYSA-N 0.000 description 3
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 3
- 235000019341 magnesium sulphate Nutrition 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- WHQSYGRFZMUQGQ-UHFFFAOYSA-N n,n-dimethylformamide;hydrate Chemical compound O.CN(C)C=O WHQSYGRFZMUQGQ-UHFFFAOYSA-N 0.000 description 3
- 239000000741 silica gel Substances 0.000 description 3
- 229910002027 silica gel Inorganic materials 0.000 description 3
- 229910052938 sodium sulfate Inorganic materials 0.000 description 3
- 235000011152 sodium sulphate Nutrition 0.000 description 3
- 239000007858 starting material Substances 0.000 description 3
- QAOWNCQODCNURD-UHFFFAOYSA-N sulfuric acid Substances OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 3
- 230000008961 swelling Effects 0.000 description 3
- 238000003786 synthesis reaction Methods 0.000 description 3
- 229940124597 therapeutic agent Drugs 0.000 description 3
- MOOUXQHCDFTMTM-UHFFFAOYSA-N 1-(2,3-dihydro-1h-indol-7-yl)ethanone Chemical compound CC(=O)C1=CC=CC2=C1NCC2 MOOUXQHCDFTMTM-UHFFFAOYSA-N 0.000 description 2
- NRWLXCRLJQEJHE-UHFFFAOYSA-N 1-acetyl-3h-indol-2-one Chemical compound C1=CC=C2N(C(=O)C)C(=O)CC2=C1 NRWLXCRLJQEJHE-UHFFFAOYSA-N 0.000 description 2
- MXVAMFYSKAUGSC-UHFFFAOYSA-N 2-(4-benzoyl-2-nitrophenyl)acetic acid Chemical compound C1=C([N+]([O-])=O)C(CC(=O)O)=CC=C1C(=O)C1=CC=CC=C1 MXVAMFYSKAUGSC-UHFFFAOYSA-N 0.000 description 2
- ICSNLGPSRYBMBD-UHFFFAOYSA-N 2-aminopyridine Chemical compound NC1=CC=CC=N1 ICSNLGPSRYBMBD-UHFFFAOYSA-N 0.000 description 2
- DJPAQYXQRCWKEH-UHFFFAOYSA-N 2-chloro-n-(3-chloro-4-fluorophenyl)acetamide Chemical compound FC1=CC=C(NC(=O)CCl)C=C1Cl DJPAQYXQRCWKEH-UHFFFAOYSA-N 0.000 description 2
- GSLTVFIVJMCNBH-UHFFFAOYSA-N 2-isocyanatopropane Chemical compound CC(C)N=C=O GSLTVFIVJMCNBH-UHFFFAOYSA-N 0.000 description 2
- DPJCXCZTLWNFOH-UHFFFAOYSA-N 2-nitroaniline Chemical compound NC1=CC=CC=C1[N+]([O-])=O DPJCXCZTLWNFOH-UHFFFAOYSA-N 0.000 description 2
- VBEVECFIAQPXQJ-UHFFFAOYSA-N 2-oxo-5-(thiophene-2-carbonyl)-3h-indole-1-carboxamide Chemical compound C=1C=C2N(C(=O)N)C(=O)CC2=CC=1C(=O)C1=CC=CS1 VBEVECFIAQPXQJ-UHFFFAOYSA-N 0.000 description 2
- XNSPDJAXCBZCRV-UHFFFAOYSA-N 4-chloro-1,3-dihydroindol-2-one Chemical compound ClC1=CC=CC2=C1CC(=O)N2 XNSPDJAXCBZCRV-UHFFFAOYSA-N 0.000 description 2
- RVFZMXCPHCAUQH-UHFFFAOYSA-N 5,7-dihydro-[1,3]dioxolo[4,5-f]indol-6-one Chemical compound C1=C2NC(=O)CC2=CC2=C1OCO2 RVFZMXCPHCAUQH-UHFFFAOYSA-N 0.000 description 2
- HRMQSJQDTTZJPC-UHFFFAOYSA-N 5-acetyl-1,3-dihydroindol-2-one Chemical compound CC(=O)C1=CC=C2NC(=O)CC2=C1 HRMQSJQDTTZJPC-UHFFFAOYSA-N 0.000 description 2
- UDKDRHMZYSHXPG-UHFFFAOYSA-N 5-acetyl-2-oxo-3h-indole-1-carboxamide Chemical compound CC(=O)C1=CC=C2N(C(N)=O)C(=O)CC2=C1 UDKDRHMZYSHXPG-UHFFFAOYSA-N 0.000 description 2
- ZOAHNOMPSPKFRF-UHFFFAOYSA-N 5-acetyl-n-benzoyl-2-oxo-3h-indole-1-carboxamide Chemical compound O=C1CC2=CC(C(=O)C)=CC=C2N1C(=O)NC(=O)C1=CC=CC=C1 ZOAHNOMPSPKFRF-UHFFFAOYSA-N 0.000 description 2
- QINDXNJHWFVYKA-UHFFFAOYSA-N 5-benzoyl-2-oxo-3h-indole-1-carboxamide Chemical compound C=1C=C2N(C(=O)N)C(=O)CC2=CC=1C(=O)C1=CC=CC=C1 QINDXNJHWFVYKA-UHFFFAOYSA-N 0.000 description 2
- VIMNAEVMZXIKFL-UHFFFAOYSA-N 5-bromo-1,3-dihydroindol-2-one Chemical compound BrC1=CC=C2NC(=O)CC2=C1 VIMNAEVMZXIKFL-UHFFFAOYSA-N 0.000 description 2
- DDIIYGHHUMKDGI-UHFFFAOYSA-N 5-fluoro-1,3-dihydroindol-2-one Chemical compound FC1=CC=C2NC(=O)CC2=C1 DDIIYGHHUMKDGI-UHFFFAOYSA-N 0.000 description 2
- FIWADZAJMKCAHJ-UHFFFAOYSA-N 5-fluoro-3-methyl-1,3-dihydroindole-2-thione Chemical compound C1=C(F)C=C2C(C)C(=S)NC2=C1 FIWADZAJMKCAHJ-UHFFFAOYSA-N 0.000 description 2
- DFGZEOUBIHLXFD-UHFFFAOYSA-N 5-methoxy-1,3-dihydroindol-2-one Chemical compound COC1=CC=C2NC(=O)CC2=C1 DFGZEOUBIHLXFD-UHFFFAOYSA-N 0.000 description 2
- AYJLPUOIDQSOLH-UHFFFAOYSA-N 6-benzoyl-1,3-dihydroindol-2-one Chemical compound C=1C=C2CC(=O)NC2=CC=1C(=O)C1=CC=CC=C1 AYJLPUOIDQSOLH-UHFFFAOYSA-N 0.000 description 2
- QDUXBJGXHPPFJG-UHFFFAOYSA-N 6-chloro-5-fluoro-1,3-dihydroindol-2-one Chemical compound C1=C(Cl)C(F)=CC2=C1NC(=O)C2 QDUXBJGXHPPFJG-UHFFFAOYSA-N 0.000 description 2
- BPBRUQDIVFLVQR-UHFFFAOYSA-N 6-chloro-5-fluoro-2-oxo-3h-indole-1-carboxamide Chemical compound FC1=C(Cl)C=C2N(C(=O)N)C(=O)CC2=C1 BPBRUQDIVFLVQR-UHFFFAOYSA-N 0.000 description 2
- KZBUYRJDOAKODT-UHFFFAOYSA-N Chlorine Chemical compound ClCl KZBUYRJDOAKODT-UHFFFAOYSA-N 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- ZAFNJMIOTHYJRJ-UHFFFAOYSA-N Diisopropyl ether Chemical compound CC(C)OC(C)C ZAFNJMIOTHYJRJ-UHFFFAOYSA-N 0.000 description 2
- XTHFKEDIFFGKHM-UHFFFAOYSA-N Dimethoxyethane Chemical compound COCCOC XTHFKEDIFFGKHM-UHFFFAOYSA-N 0.000 description 2
- AVXURJPOCDRRFD-UHFFFAOYSA-N Hydroxylamine Chemical compound ON AVXURJPOCDRRFD-UHFFFAOYSA-N 0.000 description 2
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 2
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Chemical compound OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 2
- JRNVZBWKYDBUCA-UHFFFAOYSA-N N-chlorosuccinimide Chemical compound ClN1C(=O)CCC1=O JRNVZBWKYDBUCA-UHFFFAOYSA-N 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 2
- 239000007868 Raney catalyst Substances 0.000 description 2
- NPXOKRUENSOPAO-UHFFFAOYSA-N Raney nickel Chemical compound [Al].[Ni] NPXOKRUENSOPAO-UHFFFAOYSA-N 0.000 description 2
- 229910000564 Raney nickel Inorganic materials 0.000 description 2
- KEAYESYHFKHZAL-UHFFFAOYSA-N Sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 description 2
- 238000000944 Soxhlet extraction Methods 0.000 description 2
- HEDRZPFGACZZDS-MICDWDOJSA-N Trichloro(2H)methane Chemical compound [2H]C(Cl)(Cl)Cl HEDRZPFGACZZDS-MICDWDOJSA-N 0.000 description 2
- 239000003570 air Substances 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- ILAHWRKJUDSMFH-UHFFFAOYSA-N boron tribromide Chemical compound BrB(Br)Br ILAHWRKJUDSMFH-UHFFFAOYSA-N 0.000 description 2
- 150000001768 cations Chemical class 0.000 description 2
- RNFNDJAIBTYOQL-UHFFFAOYSA-N chloral hydrate Chemical compound OC(O)C(Cl)(Cl)Cl RNFNDJAIBTYOQL-UHFFFAOYSA-N 0.000 description 2
- 229960002327 chloral hydrate Drugs 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 239000012043 crude product Substances 0.000 description 2
- 239000013078 crystal Substances 0.000 description 2
- 238000002425 crystallisation Methods 0.000 description 2
- 230000008025 crystallization Effects 0.000 description 2
- KRDUXFLIVIRGIZ-UHFFFAOYSA-N diethyl 2-(4-benzoyl-2-nitrophenyl)propanedioate Chemical compound C1=C([N+]([O-])=O)C(C(C(=O)OCC)C(=O)OCC)=CC=C1C(=O)C1=CC=CC=C1 KRDUXFLIVIRGIZ-UHFFFAOYSA-N 0.000 description 2
- NJAONFWUEGWOPG-UHFFFAOYSA-N dimethyl 2-(4-bromo-2-nitrophenyl)propanedioate Chemical compound COC(=O)C(C(=O)OC)C1=CC=C(Br)C=C1[N+]([O-])=O NJAONFWUEGWOPG-UHFFFAOYSA-N 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- SJNJERVZPASIFJ-UHFFFAOYSA-N ethyl 2-(2-amino-4-benzoylphenyl)acetate Chemical compound C1=C(N)C(CC(=O)OCC)=CC=C1C(=O)C1=CC=CC=C1 SJNJERVZPASIFJ-UHFFFAOYSA-N 0.000 description 2
- XLWFXOWSCOJHIJ-UHFFFAOYSA-N ethyl 2-(4-benzoyl-2-nitrophenyl)acetate Chemical compound C1=C([N+]([O-])=O)C(CC(=O)OCC)=CC=C1C(=O)C1=CC=CC=C1 XLWFXOWSCOJHIJ-UHFFFAOYSA-N 0.000 description 2
- IXCSERBJSXMMFS-UHFFFAOYSA-N hydrogen chloride Substances Cl.Cl IXCSERBJSXMMFS-UHFFFAOYSA-N 0.000 description 2
- 229910000041 hydrogen chloride Inorganic materials 0.000 description 2
- 239000010410 layer Substances 0.000 description 2
- KWGKDLIKAYFUFQ-UHFFFAOYSA-M lithium chloride Chemical compound [Li+].[Cl-] KWGKDLIKAYFUFQ-UHFFFAOYSA-M 0.000 description 2
- 238000002844 melting Methods 0.000 description 2
- 230000008018 melting Effects 0.000 description 2
- KHXUTOLCCFWPDH-UHFFFAOYSA-N methyl 2-(4-bromo-2-nitrophenyl)acetate Chemical compound COC(=O)CC1=CC=C(Br)C=C1[N+]([O-])=O KHXUTOLCCFWPDH-UHFFFAOYSA-N 0.000 description 2
- 239000012452 mother liquor Substances 0.000 description 2
- NENCHLFMYRQWGF-UHFFFAOYSA-N n-(2,2-dimethylpropanoyl)-2-oxo-3h-indole-1-carboxamide Chemical compound C1=CC=C2N(C(=O)NC(=O)C(C)(C)C)C(=O)CC2=C1 NENCHLFMYRQWGF-UHFFFAOYSA-N 0.000 description 2
- 229910052757 nitrogen Inorganic materials 0.000 description 2
- 239000000041 non-steroidal anti-inflammatory agent Substances 0.000 description 2
- 229940021182 non-steroidal anti-inflammatory drug Drugs 0.000 description 2
- 238000000655 nuclear magnetic resonance spectrum Methods 0.000 description 2
- 239000012044 organic layer Substances 0.000 description 2
- 239000000651 prodrug Substances 0.000 description 2
- 229940002612 prodrug Drugs 0.000 description 2
- 206010039073 rheumatoid arthritis Diseases 0.000 description 2
- QDRKDTQENPPHOJ-UHFFFAOYSA-N sodium ethoxide Chemical compound [Na+].CC[O-] QDRKDTQENPPHOJ-UHFFFAOYSA-N 0.000 description 2
- 238000010561 standard procedure Methods 0.000 description 2
- 230000003637 steroidlike Effects 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- IXZDIALLLMRYOU-UHFFFAOYSA-N tert-butyl hypochlorite Chemical compound CC(C)(C)OCl IXZDIALLLMRYOU-UHFFFAOYSA-N 0.000 description 2
- JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical compound CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 description 2
- LALLPJIGONUPCT-UHFFFAOYSA-N (2-chloro-3-nitrophenyl)-phenylmethanone Chemical compound [O-][N+](=O)C1=CC=CC(C(=O)C=2C=CC=CC=2)=C1Cl LALLPJIGONUPCT-UHFFFAOYSA-N 0.000 description 1
- AMQHEYZCDVFKJC-UHFFFAOYSA-N (2-chloro-3-nitrophenyl)-thiophen-2-ylmethanone Chemical compound [O-][N+](=O)C1=CC=CC(C(=O)C=2SC=CC=2)=C1Cl AMQHEYZCDVFKJC-UHFFFAOYSA-N 0.000 description 1
- OBCDAEXCPYRHIJ-UHFFFAOYSA-N (2-chloro-3-nitrophenyl)-thiophen-3-ylmethanone Chemical compound [O-][N+](=O)C1=CC=CC(C(=O)C2=CSC=C2)=C1Cl OBCDAEXCPYRHIJ-UHFFFAOYSA-N 0.000 description 1
- XINQFOMFQFGGCQ-UHFFFAOYSA-L (2-dodecoxy-2-oxoethyl)-[6-[(2-dodecoxy-2-oxoethyl)-dimethylazaniumyl]hexyl]-dimethylazanium;dichloride Chemical compound [Cl-].[Cl-].CCCCCCCCCCCCOC(=O)C[N+](C)(C)CCCCCC[N+](C)(C)CC(=O)OCCCCCCCCCCCC XINQFOMFQFGGCQ-UHFFFAOYSA-L 0.000 description 1
- YBDBYPQFIMSFJW-UHFFFAOYSA-N (4-chloro-3-nitrophenyl)-phenylmethanone Chemical compound C1=C(Cl)C([N+](=O)[O-])=CC(C(=O)C=2C=CC=CC=2)=C1 YBDBYPQFIMSFJW-UHFFFAOYSA-N 0.000 description 1
- IBRBMZRLVYKVRF-UHFFFAOYSA-N 1,2,4-trichloro-5-nitrobenzene Chemical compound [O-][N+](=O)C1=CC(Cl)=C(Cl)C=C1Cl IBRBMZRLVYKVRF-UHFFFAOYSA-N 0.000 description 1
- RAIPHJJURHTUIC-UHFFFAOYSA-N 1,3-thiazol-2-amine Chemical compound NC1=NC=CS1 RAIPHJJURHTUIC-UHFFFAOYSA-N 0.000 description 1
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 1
- WRGKKASJBOREMB-UHFFFAOYSA-N 1,4-dibromo-2-nitrobenzene Chemical compound [O-][N+](=O)C1=CC(Br)=CC=C1Br WRGKKASJBOREMB-UHFFFAOYSA-N 0.000 description 1
- CLNZAUGOXHAXLL-UHFFFAOYSA-N 1-(2-chloro-3-nitrophenyl)ethanone Chemical compound CC(=O)C1=CC=CC([N+]([O-])=O)=C1Cl CLNZAUGOXHAXLL-UHFFFAOYSA-N 0.000 description 1
- KINNGQJWXLNEHD-UHFFFAOYSA-N 1-(trifluoromethyl)-3h-indol-2-one Chemical class C1=CC=C2N(C(F)(F)F)C(=O)CC2=C1 KINNGQJWXLNEHD-UHFFFAOYSA-N 0.000 description 1
- KDUNBUMRZBNUJM-UHFFFAOYSA-N 1-acetyl-2-oxo-n-phenyl-3h-indole-3-carboxamide Chemical compound C12=CC=CC=C2N(C(=O)C)C(=O)C1C(=O)NC1=CC=CC=C1 KDUNBUMRZBNUJM-UHFFFAOYSA-N 0.000 description 1
- BGJIBXMUNLQWMZ-UHFFFAOYSA-N 1-acetyl-5-chloro-3h-indol-2-one Chemical compound ClC1=CC=C2N(C(=O)C)C(=O)CC2=C1 BGJIBXMUNLQWMZ-UHFFFAOYSA-N 0.000 description 1
- WWBQKHDTVLEKKZ-UHFFFAOYSA-N 1-acetyl-6-chloro-5-fluoro-3h-indol-2-one Chemical compound FC1=C(Cl)C=C2N(C(=O)C)C(=O)CC2=C1 WWBQKHDTVLEKKZ-UHFFFAOYSA-N 0.000 description 1
- HLYBPRLSHVLKLU-UHFFFAOYSA-N 1-bromo-3h-indol-2-one Chemical class C1=CC=C2N(Br)C(=O)CC2=C1 HLYBPRLSHVLKLU-UHFFFAOYSA-N 0.000 description 1
- BVJVGBIIZGRMIY-UHFFFAOYSA-N 1-cyclobutyl-3h-indol-2-one Chemical class O=C1CC2=CC=CC=C2N1C1CCC1 BVJVGBIIZGRMIY-UHFFFAOYSA-N 0.000 description 1
- LLGBZZJOICJSAL-UHFFFAOYSA-N 1h-indol-7-yl acetate Chemical compound CC(=O)OC1=CC=CC2=C1NC=C2 LLGBZZJOICJSAL-UHFFFAOYSA-N 0.000 description 1
- LTMRRSWNXVJMBA-UHFFFAOYSA-L 2,2-diethylpropanedioate Chemical compound CCC(CC)(C([O-])=O)C([O-])=O LTMRRSWNXVJMBA-UHFFFAOYSA-L 0.000 description 1
- HNENEALJPWJWJY-UHFFFAOYSA-N 2,4-difluoro-1-isocyanatobenzene Chemical compound FC1=CC=C(N=C=O)C(F)=C1 HNENEALJPWJWJY-UHFFFAOYSA-N 0.000 description 1
- BIKPIFGPFVNIGE-UHFFFAOYSA-N 2-butylsulfanylaniline Chemical compound CCCCSC1=CC=CC=C1N BIKPIFGPFVNIGE-UHFFFAOYSA-N 0.000 description 1
- WBRPQQSADOCKCH-UHFFFAOYSA-N 2-methylsulfanylaniline Chemical compound CSC1=CC=CC=C1N WBRPQQSADOCKCH-UHFFFAOYSA-N 0.000 description 1
- JOIMMTCVFICSRN-UHFFFAOYSA-N 2-oxo-6-(trifluoromethyl)-3h-indole-1-carboxamide Chemical compound C1=C(C(F)(F)F)C=C2N(C(=O)N)C(=O)CC2=C1 JOIMMTCVFICSRN-UHFFFAOYSA-N 0.000 description 1
- TWRSDKHQGTYMOV-UHFFFAOYSA-N 2-oxo-n-propan-2-yl-3h-indole-1-carboxamide Chemical compound C1=CC=C2N(C(=O)NC(C)C)C(=O)CC2=C1 TWRSDKHQGTYMOV-UHFFFAOYSA-N 0.000 description 1
- YSEMCVGMNUUNRK-UHFFFAOYSA-N 3-chloro-4-fluoroaniline Chemical compound NC1=CC=C(F)C(Cl)=C1 YSEMCVGMNUUNRK-UHFFFAOYSA-N 0.000 description 1
- PNPCRKVUWYDDST-UHFFFAOYSA-N 3-chloroaniline Chemical compound NC1=CC=CC(Cl)=C1 PNPCRKVUWYDDST-UHFFFAOYSA-N 0.000 description 1
- KKHJTHLWDZQCFP-UHFFFAOYSA-N 3-cyclohexylaniline Chemical compound NC1=CC=CC(C2CCCCC2)=C1 KKHJTHLWDZQCFP-UHFFFAOYSA-N 0.000 description 1
- XJCVRTZCHMZPBD-UHFFFAOYSA-N 3-nitroaniline Chemical compound NC1=CC=CC([N+]([O-])=O)=C1 XJCVRTZCHMZPBD-UHFFFAOYSA-N 0.000 description 1
- RVFYSTJIJULFHI-UHFFFAOYSA-N 4,6-difluoro-1,3-dihydroindol-2-one Chemical compound FC1=CC(F)=CC2=C1CC(=O)N2 RVFYSTJIJULFHI-UHFFFAOYSA-N 0.000 description 1
- LVXWMUMMJRHVPF-UHFFFAOYSA-N 4,7-dichloro-1,3-dihydroindol-2-one Chemical compound ClC1=CC=C(Cl)C2=C1CC(=O)N2 LVXWMUMMJRHVPF-UHFFFAOYSA-N 0.000 description 1
- VHYFNPMBLIVWCW-UHFFFAOYSA-N 4-Dimethylaminopyridine Chemical compound CN(C)C1=CC=NC=C1 VHYFNPMBLIVWCW-UHFFFAOYSA-N 0.000 description 1
- ALYINIXLHQDLLF-UHFFFAOYSA-N 4-acetyl-1,3-dihydroindol-2-one Chemical compound CC(=O)C1=CC=CC2=C1CC(=O)N2 ALYINIXLHQDLLF-UHFFFAOYSA-N 0.000 description 1
- NCKMRUDWQDBPAO-UHFFFAOYSA-N 4-benzoyl-1,3-dihydroindol-2-one Chemical compound C=1C=CC=2NC(=O)CC=2C=1C(=O)C1=CC=CC=C1 NCKMRUDWQDBPAO-UHFFFAOYSA-N 0.000 description 1
- PJTZNVWIFVMORN-UHFFFAOYSA-N 4-chloro-5-fluoro-1,3-dihydroindol-2-one Chemical compound FC1=CC=C2NC(=O)CC2=C1Cl PJTZNVWIFVMORN-UHFFFAOYSA-N 0.000 description 1
- PFXOURUQNDVNGH-UHFFFAOYSA-N 4-chloro-5-methyl-1,3-dihydroindol-2-one Chemical compound CC1=CC=C2NC(=O)CC2=C1Cl PFXOURUQNDVNGH-UHFFFAOYSA-N 0.000 description 1
- LPBWEMHFJIWLDB-UHFFFAOYSA-N 4-cycloheptylaniline Chemical compound C1=CC(N)=CC=C1C1CCCCCC1 LPBWEMHFJIWLDB-UHFFFAOYSA-N 0.000 description 1
- JLNMBIKJQAKQBH-UHFFFAOYSA-N 4-cyclohexylaniline Chemical compound C1=CC(N)=CC=C1C1CCCCC1 JLNMBIKJQAKQBH-UHFFFAOYSA-N 0.000 description 1
- SSCHHQOLJQJASK-UHFFFAOYSA-N 4-ethyl-1,3-dihydroindol-2-one Chemical compound CCC1=CC=CC2=C1CC(=O)N2 SSCHHQOLJQJASK-UHFFFAOYSA-N 0.000 description 1
- BOGOFYGSFNVQFK-UHFFFAOYSA-N 4-fluoro-6-(thiophene-2-carbonyl)-1,3-dihydroindol-2-one Chemical compound C=1C=2NC(=O)CC=2C(F)=CC=1C(=O)C1=CC=CS1 BOGOFYGSFNVQFK-UHFFFAOYSA-N 0.000 description 1
- CDKUBPGAOOZNLI-UHFFFAOYSA-N 4-fluoro-7-(trifluoromethyl)-1,3-dihydroindol-2-one Chemical compound FC1=CC=C(C(F)(F)F)C2=C1CC(=O)N2 CDKUBPGAOOZNLI-UHFFFAOYSA-N 0.000 description 1
- KRZCOLNOCZKSDF-UHFFFAOYSA-N 4-fluoroaniline Chemical compound NC1=CC=C(F)C=C1 KRZCOLNOCZKSDF-UHFFFAOYSA-N 0.000 description 1
- PGBYMPJXTSIZEC-UHFFFAOYSA-N 4-hydroxy-2-methyl-n-pyridin-2-yl-1,2-benzothiazine-3-carboxamide Chemical class CN1SC2=CC=CC=C2C(O)=C1C(=O)NC1=CC=CC=N1 PGBYMPJXTSIZEC-UHFFFAOYSA-N 0.000 description 1
- USRZZPHRQZGXFH-UHFFFAOYSA-N 4-methyl-1,3-dihydroindol-2-one Chemical compound CC1=CC=CC2=C1CC(=O)N2 USRZZPHRQZGXFH-UHFFFAOYSA-N 0.000 description 1
- XRWBASUXZZAQQR-UHFFFAOYSA-N 4-methyl-1,3-dihydroindole-2-thione Chemical compound CC1=CC=CC2=C1CC(=S)N2 XRWBASUXZZAQQR-UHFFFAOYSA-N 0.000 description 1
- XFOZJAVSNMSLGJ-UHFFFAOYSA-N 4-methyl-6-(thiophene-2-carbonyl)-1,3-dihydroindol-2-one Chemical compound C=1C=2NC(=O)CC=2C(C)=CC=1C(=O)C1=CC=CS1 XFOZJAVSNMSLGJ-UHFFFAOYSA-N 0.000 description 1
- IRRYHCKXXXCMJP-UHFFFAOYSA-N 4-methyl-6-(trifluoromethyl)-1,3-dihydroindol-2-one Chemical compound CC1=CC(C(F)(F)F)=CC2=C1CC(=O)N2 IRRYHCKXXXCMJP-UHFFFAOYSA-N 0.000 description 1
- CTXRGOGLJBVZJS-UHFFFAOYSA-N 4-methylsulfanyl-6-(thiophene-3-carbonyl)-1,3-dihydroindol-2-one Chemical compound C=1C=2NC(=O)CC=2C(SC)=CC=1C(=O)C=1C=CSC=1 CTXRGOGLJBVZJS-UHFFFAOYSA-N 0.000 description 1
- PZHFERQADHACDR-UHFFFAOYSA-N 4-propylsulfanylaniline Chemical compound CCCSC1=CC=C(N)C=C1 PZHFERQADHACDR-UHFFFAOYSA-N 0.000 description 1
- ADDAYZCZQHOPJX-UHFFFAOYSA-N 5,6-dichloro-1,3-dihydroindol-2-one Chemical compound C1=C(Cl)C(Cl)=CC2=C1NC(=O)C2 ADDAYZCZQHOPJX-UHFFFAOYSA-N 0.000 description 1
- HYDGYCWXHIDUDK-UHFFFAOYSA-N 5,6-dichloro-2-oxo-3h-indole-1-carboxamide Chemical compound ClC1=C(Cl)C=C2N(C(=O)N)C(=O)CC2=C1 HYDGYCWXHIDUDK-UHFFFAOYSA-N 0.000 description 1
- SHPZWXNWJLWGQK-UHFFFAOYSA-N 5,7-difluoro-1,3-dihydroindol-2-one Chemical compound FC1=CC(F)=CC2=C1NC(=O)C2 SHPZWXNWJLWGQK-UHFFFAOYSA-N 0.000 description 1
- DJUVRTVJSHICLO-UHFFFAOYSA-N 5-(thiophene-2-carbonyl)-1,3-dihydroindol-2-one Chemical compound C=1C=C2NC(=O)CC2=CC=1C(=O)C1=CC=CS1 DJUVRTVJSHICLO-UHFFFAOYSA-N 0.000 description 1
- LHZZMXTWLFDEPS-UHFFFAOYSA-N 5-(thiophene-3-carbonyl)-1,3-dihydroindol-2-one Chemical compound C=1C=C2NC(=O)CC2=CC=1C(=O)C=1C=CSC=1 LHZZMXTWLFDEPS-UHFFFAOYSA-N 0.000 description 1
- XHDJYQWGFIBCEP-UHFFFAOYSA-N 5-Chloro-1H-indole-2,3-dione Chemical compound ClC1=CC=C2NC(=O)C(=O)C2=C1 XHDJYQWGFIBCEP-UHFFFAOYSA-N 0.000 description 1
- OCYVNBVTNJYYRC-UHFFFAOYSA-N 5-acetyl-2-oxo-n-phenyl-3h-indole-1-carboxamide Chemical compound O=C1CC2=CC(C(=O)C)=CC=C2N1C(=O)NC1=CC=CC=C1 OCYVNBVTNJYYRC-UHFFFAOYSA-N 0.000 description 1
- YJQVIORMQWIHBC-UHFFFAOYSA-N 5-acetyl-4-chloro-1,3-dihydroindol-2-one Chemical compound CC(=O)C1=CC=C2NC(=O)CC2=C1Cl YJQVIORMQWIHBC-UHFFFAOYSA-N 0.000 description 1
- WQWDSLLMLWFMPS-UHFFFAOYSA-N 5-acetyl-4-methyl-1,3-dihydroindol-2-one Chemical compound CC(=O)C1=CC=C2NC(=O)CC2=C1C WQWDSLLMLWFMPS-UHFFFAOYSA-N 0.000 description 1
- DZNAJEDQDMDIEL-UHFFFAOYSA-N 5-benzoyl-1,3-dihydroindol-2-one Chemical compound C=1C=C2NC(=O)CC2=CC=1C(=O)C1=CC=CC=C1 DZNAJEDQDMDIEL-UHFFFAOYSA-N 0.000 description 1
- CSVKDKOGMYMXDE-UHFFFAOYSA-N 5-benzoyl-7-methyl-1,3-dihydroindol-2-one Chemical compound C=1C=2CC(=O)NC=2C(C)=CC=1C(=O)C1=CC=CC=C1 CSVKDKOGMYMXDE-UHFFFAOYSA-N 0.000 description 1
- GHPQWQADSFMXFH-UHFFFAOYSA-N 5-bromo-7-(thiophene-2-carbonyl)-1,3-dihydroindol-2-one Chemical compound C=1C(Br)=CC=2CC(=O)NC=2C=1C(=O)C1=CC=CS1 GHPQWQADSFMXFH-UHFFFAOYSA-N 0.000 description 1
- JIMGOAVTDLBHHF-UHFFFAOYSA-N 5-butoxy-7-methyl-1,3-dihydroindol-2-one Chemical compound CC1=CC(OCCCC)=CC2=C1NC(=O)C2 JIMGOAVTDLBHHF-UHFFFAOYSA-N 0.000 description 1
- WIEJKTTWCGNQHH-UHFFFAOYSA-N 5-butyl-1h-indole-2,3-dione Chemical compound CCCCC1=CC=C2NC(=O)C(=O)C2=C1 WIEJKTTWCGNQHH-UHFFFAOYSA-N 0.000 description 1
- KSAFFYXMLNVLNV-UHFFFAOYSA-N 5-butyl-7-fluoro-1,3-dihydroindol-2-one Chemical compound FC1=CC(CCCC)=CC2=C1NC(=O)C2 KSAFFYXMLNVLNV-UHFFFAOYSA-N 0.000 description 1
- WWJLCYHYLZZXBE-UHFFFAOYSA-N 5-chloro-1,3-dihydroindol-2-one Chemical compound ClC1=CC=C2NC(=O)CC2=C1 WWJLCYHYLZZXBE-UHFFFAOYSA-N 0.000 description 1
- JAVVEKKIDKRVPH-UHFFFAOYSA-N 5-chloro-1-(2-methylpropanoyl)-3h-indol-2-one Chemical compound ClC1=CC=C2N(C(=O)C(C)C)C(=O)CC2=C1 JAVVEKKIDKRVPH-UHFFFAOYSA-N 0.000 description 1
- QAAUYMHNDJZQMV-UHFFFAOYSA-N 5-chloro-6-cyclohexyl-2-oxo-3h-indole-1-carboxamide Chemical compound C1=C2N(C(=O)N)C(=O)CC2=CC(Cl)=C1C1CCCCC1 QAAUYMHNDJZQMV-UHFFFAOYSA-N 0.000 description 1
- YZYLXNPSGVLBST-UHFFFAOYSA-N 5-cycloheptyl-1,3-dihydroindol-2-one Chemical class C=1C=C2NC(=O)CC2=CC=1C1CCCCCC1 YZYLXNPSGVLBST-UHFFFAOYSA-N 0.000 description 1
- UKNVMAPOVWLHAP-UHFFFAOYSA-N 5-cycloheptyl-1h-indole-2,3-dione Chemical compound C1=C2C(=O)C(=O)NC2=CC=C1C1CCCCCC1 UKNVMAPOVWLHAP-UHFFFAOYSA-N 0.000 description 1
- UTVCQNZUTJOXLW-UHFFFAOYSA-N 5-cyclohexyl-n-(4-methoxyphenyl)-2-oxo-3h-indole-1-carboxamide Chemical compound C1=CC(OC)=CC=C1NC(=O)N1C2=CC=C(C3CCCCC3)C=C2CC1=O UTVCQNZUTJOXLW-UHFFFAOYSA-N 0.000 description 1
- DYTNNGQPYKZMNF-UHFFFAOYSA-N 5-ethoxy-1,3-dihydroindol-2-one Chemical class CCOC1=CC=C2NC(=O)CC2=C1 DYTNNGQPYKZMNF-UHFFFAOYSA-N 0.000 description 1
- WYSDSJWLAUUUFD-UHFFFAOYSA-N 5-ethoxy-7-methyl-1,3-dihydroindol-2-one Chemical compound CC1=CC(OCC)=CC2=C1NC(=O)C2 WYSDSJWLAUUUFD-UHFFFAOYSA-N 0.000 description 1
- NIAQNPSMKWBDLH-UHFFFAOYSA-N 5-fluoro-6-nitro-1,3-dihydroindol-2-one Chemical compound C1=C(F)C([N+](=O)[O-])=CC2=C1CC(=O)N2 NIAQNPSMKWBDLH-UHFFFAOYSA-N 0.000 description 1
- SYJHBRHSEPKLMR-UHFFFAOYSA-N 5-methyl-2-oxo-3h-indole-1-carboxamide Chemical compound CC1=CC=C2N(C(N)=O)C(=O)CC2=C1 SYJHBRHSEPKLMR-UHFFFAOYSA-N 0.000 description 1
- JQCGHRDKVZPCRO-UHFFFAOYSA-N 5-nitro-1,3-dihydroindol-2-one Chemical compound [O-][N+](=O)C1=CC=C2NC(=O)CC2=C1 JQCGHRDKVZPCRO-UHFFFAOYSA-N 0.000 description 1
- NCPKYLVJWGEWOH-UHFFFAOYSA-N 5-nitro-2-oxo-3h-indole-1-carboxamide Chemical compound [O-][N+](=O)C1=CC=C2N(C(=O)N)C(=O)CC2=C1 NCPKYLVJWGEWOH-UHFFFAOYSA-N 0.000 description 1
- UODWXGIKDWMDLJ-UHFFFAOYSA-N 5-nitro-2-oxo-n-phenyl-3h-indole-1-carboxamide Chemical compound O=C1CC2=CC([N+](=O)[O-])=CC=C2N1C(=O)NC1=CC=CC=C1 UODWXGIKDWMDLJ-UHFFFAOYSA-N 0.000 description 1
- ONBGICIXOGGEDN-UHFFFAOYSA-N 5-propanoyl-1,3-dihydroindol-2-one Chemical compound CCC(=O)C1=CC=C2NC(=O)CC2=C1 ONBGICIXOGGEDN-UHFFFAOYSA-N 0.000 description 1
- LIKZTKKCQSBPLE-UHFFFAOYSA-N 5-propyl-1,3-dihydroindole-2-thione Chemical compound CCCC1=CC=C2NC(=S)CC2=C1 LIKZTKKCQSBPLE-UHFFFAOYSA-N 0.000 description 1
- KGDOROXGRZKTSA-UHFFFAOYSA-N 6,8-dihydro-[1,3]dioxolo[4,5-e]indol-7-one Chemical compound N1C(=O)CC2=C1C=CC1=C2OCO1 KGDOROXGRZKTSA-UHFFFAOYSA-N 0.000 description 1
- DDHCNKKFIHFNAB-UHFFFAOYSA-N 6,8-dihydro-[1,3]dioxolo[4,5-g]indol-7-one Chemical compound C1=C2OCOC2=C2NC(=O)CC2=C1 DDHCNKKFIHFNAB-UHFFFAOYSA-N 0.000 description 1
- GRAKDIRWMKYAIA-UHFFFAOYSA-N 6-(thiophene-2-carbonyl)-1,3-dihydroindol-2-one Chemical compound C=1C=C2CC(=O)NC2=CC=1C(=O)C1=CC=CS1 GRAKDIRWMKYAIA-UHFFFAOYSA-N 0.000 description 1
- TVTBJXBUOZBHET-UHFFFAOYSA-N 6-(thiophene-3-carbonyl)-1,3-dihydroindol-2-one Chemical compound C=1C=C2CC(=O)NC2=CC=1C(=O)C=1C=CSC=1 TVTBJXBUOZBHET-UHFFFAOYSA-N 0.000 description 1
- LZPKWQOLOCLSBO-UHFFFAOYSA-N 6-(trifluoromethyl)-1,3-dihydroindol-2-one Chemical compound FC(F)(F)C1=CC=C2CC(=O)NC2=C1 LZPKWQOLOCLSBO-UHFFFAOYSA-N 0.000 description 1
- LTDDCBMGQOXJMM-UHFFFAOYSA-N 6-acetyl-4-fluoro-1,3-dihydroindol-2-one Chemical compound FC1=CC(C(=O)C)=CC2=C1CC(=O)N2 LTDDCBMGQOXJMM-UHFFFAOYSA-N 0.000 description 1
- DUULZSPILMDJNV-UHFFFAOYSA-N 6-benzoyl-4-chloro-1,3-dihydroindol-2-one Chemical compound C=1C=2NC(=O)CC=2C(Cl)=CC=1C(=O)C1=CC=CC=C1 DUULZSPILMDJNV-UHFFFAOYSA-N 0.000 description 1
- OJDPZEHFGRYXDJ-UHFFFAOYSA-N 6-benzoyl-4-methoxy-1,3-dihydroindol-2-one Chemical compound C=1C=2NC(=O)CC=2C(OC)=CC=1C(=O)C1=CC=CC=C1 OJDPZEHFGRYXDJ-UHFFFAOYSA-N 0.000 description 1
- JARRYVQFBQVOBE-UHFFFAOYSA-N 6-bromo-1,3-dihydroindol-2-one Chemical compound BrC1=CC=C2CC(=O)NC2=C1 JARRYVQFBQVOBE-UHFFFAOYSA-N 0.000 description 1
- XTTAABMRMMRTBE-UHFFFAOYSA-N 6-butanoyl-4-methoxy-1,3-dihydroindol-2-one Chemical compound COC1=CC(C(=O)CCC)=CC2=C1CC(=O)N2 XTTAABMRMMRTBE-UHFFFAOYSA-N 0.000 description 1
- GGELTTOSVBZZPQ-UHFFFAOYSA-N 6-butyl-4-chloro-1,3-dihydroindole-2-thione Chemical compound ClC1=CC(CCCC)=CC2=C1CC(=S)N2 GGELTTOSVBZZPQ-UHFFFAOYSA-N 0.000 description 1
- CENVPIZOTHULGJ-UHFFFAOYSA-N 6-chloro-1,3-dihydroindol-2-one Chemical compound ClC1=CC=C2CC(=O)NC2=C1 CENVPIZOTHULGJ-UHFFFAOYSA-N 0.000 description 1
- XNHPJPILBKTSNQ-UHFFFAOYSA-N 6-cyclohexyl-1,3-dihydroindol-2-one Chemical class C1=C2NC(=O)CC2=CC=C1C1CCCCC1 XNHPJPILBKTSNQ-UHFFFAOYSA-N 0.000 description 1
- GGXVWWWOOQQLQR-UHFFFAOYSA-N 6-fluoro-5-nitro-2-oxo-n-phenyl-3h-indole-1-carboxamide Chemical compound C1=2C=C(F)C([N+](=O)[O-])=CC=2CC(=O)N1C(=O)NC1=CC=CC=C1 GGXVWWWOOQQLQR-UHFFFAOYSA-N 0.000 description 1
- YMEDIIPYCPCXTC-UHFFFAOYSA-N 6-methoxy-7-methyl-1,3-dihydroindol-2-one Chemical compound COC1=CC=C2CC(=O)NC2=C1C YMEDIIPYCPCXTC-UHFFFAOYSA-N 0.000 description 1
- BFCDUCCWAPLDJQ-UHFFFAOYSA-N 6-methyl-1,3-dihydroindol-2-one Chemical compound CC1=CC=C2CC(=O)NC2=C1 BFCDUCCWAPLDJQ-UHFFFAOYSA-N 0.000 description 1
- YCSRYPJGUGUNGB-UHFFFAOYSA-N 6-methyl-1,3-dihydroindole-2-thione Chemical compound CC1=CC=C2CC(=S)NC2=C1 YCSRYPJGUGUNGB-UHFFFAOYSA-N 0.000 description 1
- XDPJONVAYXUZES-UHFFFAOYSA-N 6-propyl-1,3-dihydroindol-2-one Chemical compound CCCC1=CC=C2CC(=O)NC2=C1 XDPJONVAYXUZES-UHFFFAOYSA-N 0.000 description 1
- XFFDQSICOLSGAA-UHFFFAOYSA-N 7-(thiophene-2-carbonyl)-1,3-dihydroindol-2-one Chemical compound C=1C=CC=2CC(=O)NC=2C=1C(=O)C1=CC=CS1 XFFDQSICOLSGAA-UHFFFAOYSA-N 0.000 description 1
- QAZXPEDJCKQERX-UHFFFAOYSA-N 7-(thiophene-3-carbonyl)-1,3-dihydroindol-2-one Chemical compound C=1C=CC=2CC(=O)NC=2C=1C(=O)C=1C=CSC=1 QAZXPEDJCKQERX-UHFFFAOYSA-N 0.000 description 1
- ODADMQRQVQRBAC-UHFFFAOYSA-N 7-(trifluoromethyl)-1,3-dihydroindol-2-one Chemical class FC(F)(F)C1=CC=CC2=C1NC(=O)C2 ODADMQRQVQRBAC-UHFFFAOYSA-N 0.000 description 1
- UXIOZBFBKHXCTA-UHFFFAOYSA-N 7-acetyl-5-methyl-1,3-dihydroindol-2-one Chemical compound CC(=O)C1=CC(C)=CC2=C1NC(=O)C2 UXIOZBFBKHXCTA-UHFFFAOYSA-N 0.000 description 1
- AGWDYMMGORETTB-UHFFFAOYSA-N 7-acetyl-5-methylsulfanyl-1,3-dihydroindol-2-one Chemical compound CC(=O)C1=CC(SC)=CC2=C1NC(=O)C2 AGWDYMMGORETTB-UHFFFAOYSA-N 0.000 description 1
- APGQYYFHBPQPTL-UHFFFAOYSA-N 7-benzoyl-1,3-dihydroindol-2-one Chemical compound C=1C=CC=2CC(=O)NC=2C=1C(=O)C1=CC=CC=C1 APGQYYFHBPQPTL-UHFFFAOYSA-N 0.000 description 1
- RTYPQDVHXLSPFJ-UHFFFAOYSA-N 7-benzoyl-5-fluoro-1,3-dihydroindol-2-one Chemical compound C=1C(F)=CC=2CC(=O)NC=2C=1C(=O)C1=CC=CC=C1 RTYPQDVHXLSPFJ-UHFFFAOYSA-N 0.000 description 1
- WSUWXWBRIBGIQT-UHFFFAOYSA-N 7-bromo-1,3-dihydroindol-2-one Chemical compound BrC1=CC=CC2=C1NC(=O)C2 WSUWXWBRIBGIQT-UHFFFAOYSA-N 0.000 description 1
- OBAUUYGNNFZTAR-UHFFFAOYSA-N 7-butyl-1,3-dihydroindole-2-thione Chemical class CCCCC1=CC=CC2=C1NC(=S)C2 OBAUUYGNNFZTAR-UHFFFAOYSA-N 0.000 description 1
- LGGMPECXZLJRCP-UHFFFAOYSA-N 7-cyclohexyl-1,3-dihydroindol-2-one Chemical compound C=12NC(=O)CC2=CC=CC=1C1CCCCC1 LGGMPECXZLJRCP-UHFFFAOYSA-N 0.000 description 1
- GMYORWXVZUOSIZ-UHFFFAOYSA-N 7-cyclopropyl-1,3-dihydroindol-2-one Chemical compound C=12NC(=O)CC2=CC=CC=1C1CC1 GMYORWXVZUOSIZ-UHFFFAOYSA-N 0.000 description 1
- VMUIOEOYZHJLEZ-UHFFFAOYSA-N 7-fluoro-1,3-dihydroindol-2-one Chemical compound FC1=CC=CC2=C1NC(=O)C2 VMUIOEOYZHJLEZ-UHFFFAOYSA-N 0.000 description 1
- UAIKQUZQXSTAKX-UHFFFAOYSA-N 7-methyl-1,3-dihydroindol-2-one Chemical compound CC1=CC=CC2=C1NC(=O)C2 UAIKQUZQXSTAKX-UHFFFAOYSA-N 0.000 description 1
- VGANBSWHOYEFKJ-UHFFFAOYSA-N 7-nitro-1,3-dihydroindol-2-one Chemical compound [O-][N+](=O)C1=CC=CC2=C1NC(=O)C2 VGANBSWHOYEFKJ-UHFFFAOYSA-N 0.000 description 1
- UKPODTDFPJNMTE-UHFFFAOYSA-N 7-propanoyl-1,3-dihydroindol-2-one Chemical compound CCC(=O)C1=CC=CC2=C1NC(=O)C2 UKPODTDFPJNMTE-UHFFFAOYSA-N 0.000 description 1
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 description 1
- DRDOTOLDUORFTI-UHFFFAOYSA-N COC1=CC=C(C=C1)N1C(C(C2=CC(=C(C=C12)F)Cl)C(N)=O)=O Chemical compound COC1=CC=C(C=C1)N1C(C(C2=CC(=C(C=C12)F)Cl)C(N)=O)=O DRDOTOLDUORFTI-UHFFFAOYSA-N 0.000 description 1
- VGCXGMAHQTYDJK-UHFFFAOYSA-N Chloroacetyl chloride Chemical compound ClCC(Cl)=O VGCXGMAHQTYDJK-UHFFFAOYSA-N 0.000 description 1
- XDTMQSROBMDMFD-UHFFFAOYSA-N Cyclohexane Chemical compound C1CCCCC1 XDTMQSROBMDMFD-UHFFFAOYSA-N 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- QMMFVYPAHWMCMS-UHFFFAOYSA-N Dimethyl sulfide Chemical group CSC QMMFVYPAHWMCMS-UHFFFAOYSA-N 0.000 description 1
- FVIGODVHAVLZOO-UHFFFAOYSA-N Dixanthogen Chemical compound CCOC(=S)SSC(=S)OCC FVIGODVHAVLZOO-UHFFFAOYSA-N 0.000 description 1
- 101100396994 Drosophila melanogaster Inos gene Proteins 0.000 description 1
- MDIAKIHKBBNYHF-UHFFFAOYSA-N Ethyl 2-(methylthio)acetate Chemical compound CCOC(=O)CSC MDIAKIHKBBNYHF-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- SIKJAQJRHWYJAI-UHFFFAOYSA-N Indole Chemical compound C1=CC=C2NC=CC2=C1 SIKJAQJRHWYJAI-UHFFFAOYSA-N 0.000 description 1
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- 238000005481 NMR spectroscopy Methods 0.000 description 1
- FNNHLHDCOJVHQF-UHFFFAOYSA-N O(C)C1=CC=C(C=C1)N1C(C(C2=CC3=C(C=C12)OCO3)C(N)=O)=O Chemical compound O(C)C1=CC=C(C=C1)N1C(C(C2=CC3=C(C=C12)OCO3)C(N)=O)=O FNNHLHDCOJVHQF-UHFFFAOYSA-N 0.000 description 1
- 206010030124 Oedema peripheral Diseases 0.000 description 1
- 201000004681 Psoriasis Diseases 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- PHZYZQWQIQMLBY-UHFFFAOYSA-N acetonitrile;propan-1-ol Chemical compound CC#N.CCCO PHZYZQWQIQMLBY-UHFFFAOYSA-N 0.000 description 1
- 150000008065 acid anhydrides Chemical class 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 235000019270 ammonium chloride Nutrition 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 229940035676 analgesics Drugs 0.000 description 1
- 238000011861 anti-inflammatory therapy Methods 0.000 description 1
- 230000002917 arthritic effect Effects 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- PASDCCFISLVPSO-UHFFFAOYSA-N benzoyl chloride Chemical compound ClC(=O)C1=CC=CC=C1 PASDCCFISLVPSO-UHFFFAOYSA-N 0.000 description 1
- LURYMYITPCOQAU-UHFFFAOYSA-N benzoyl isocyanate Chemical compound O=C=NC(=O)C1=CC=CC=C1 LURYMYITPCOQAU-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 125000001246 bromo group Chemical group Br* 0.000 description 1
- 206010006451 bronchitis Diseases 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- OSBXKXBQYJUFEW-UHFFFAOYSA-N carbamoyl 2-oxo-1,3-dihydroindole-3-carboxylate Chemical class C1=CC=C2C(C(=O)OC(=O)N)C(=O)NC2=C1 OSBXKXBQYJUFEW-UHFFFAOYSA-N 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 150000004649 carbonic acid derivatives Chemical class 0.000 description 1
- 229920001525 carrageenan Polymers 0.000 description 1
- 235000010418 carrageenan Nutrition 0.000 description 1
- 239000003054 catalyst Substances 0.000 description 1
- 238000005660 chlorination reaction Methods 0.000 description 1
- WRJWRGBVPUUDLA-UHFFFAOYSA-N chlorosulfonyl isocyanate Chemical compound ClS(=O)(=O)N=C=O WRJWRGBVPUUDLA-UHFFFAOYSA-N 0.000 description 1
- 239000004927 clay Substances 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 238000010908 decantation Methods 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- BEPAFCGSDWSTEL-UHFFFAOYSA-N dimethyl malonate Chemical compound COC(=O)CC(=O)OC BEPAFCGSDWSTEL-UHFFFAOYSA-N 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000010828 elution Methods 0.000 description 1
- 230000001804 emulsifying effect Effects 0.000 description 1
- 230000032050 esterification Effects 0.000 description 1
- 238000005886 esterification reaction Methods 0.000 description 1
- RIFGWPKJUGCATF-UHFFFAOYSA-N ethyl chloroformate Chemical compound CCOC(Cl)=O RIFGWPKJUGCATF-UHFFFAOYSA-N 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 150000002391 heterocyclic compounds Chemical class 0.000 description 1
- MOTRZVVGCFFABN-UHFFFAOYSA-N hexane;2-propan-2-yloxypropane Chemical compound CCCCCC.CC(C)OC(C)C MOTRZVVGCFFABN-UHFFFAOYSA-N 0.000 description 1
- 150000004679 hydroxides Chemical class 0.000 description 1
- 238000011065 in-situ storage Methods 0.000 description 1
- 208000027866 inflammatory disease Diseases 0.000 description 1
- 238000002329 infrared spectrum Methods 0.000 description 1
- ZWVCLTBRPBMWKG-UHFFFAOYSA-N methyl 2-(2-nitro-1,3-benzodioxol-4-yl)acetate Chemical compound COC(=O)CC1=CC=CC2=C1OC([N+]([O-])=O)O2 ZWVCLTBRPBMWKG-UHFFFAOYSA-N 0.000 description 1
- WNLQVFDKMDHWGP-UHFFFAOYSA-N methyl 2-(6-nitro-1,3-benzodioxol-5-yl)acetate Chemical compound C1=C([N+]([O-])=O)C(CC(=O)OC)=CC2=C1OCO2 WNLQVFDKMDHWGP-UHFFFAOYSA-N 0.000 description 1
- PGXWDLGWMQIXDT-UHFFFAOYSA-N methylsulfinylmethane;hydrate Chemical compound O.CS(C)=O PGXWDLGWMQIXDT-UHFFFAOYSA-N 0.000 description 1
- BHAAPTBBJKJZER-UHFFFAOYSA-N p-anisidine Chemical compound COC1=CC=C(N)C=C1 BHAAPTBBJKJZER-UHFFFAOYSA-N 0.000 description 1
- 238000007911 parenteral administration Methods 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- 239000000825 pharmaceutical preparation Substances 0.000 description 1
- QYSPLQLAKJAUJT-UHFFFAOYSA-N piroxicam Chemical compound OC=1C2=CC=CC=C2S(=O)(=O)N(C)C=1C(=O)NC1=CC=CC=N1 QYSPLQLAKJAUJT-UHFFFAOYSA-N 0.000 description 1
- 229960002702 piroxicam Drugs 0.000 description 1
- 229910001414 potassium ion Inorganic materials 0.000 description 1
- 230000003389 potentiating effect Effects 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 1
- 239000012429 reaction media Substances 0.000 description 1
- 201000003068 rheumatic fever Diseases 0.000 description 1
- 238000007363 ring formation reaction Methods 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 235000017557 sodium bicarbonate Nutrition 0.000 description 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 239000012312 sodium hydride Substances 0.000 description 1
- 229910000104 sodium hydride Inorganic materials 0.000 description 1
- 229910001415 sodium ion Inorganic materials 0.000 description 1
- 238000001179 sorption measurement Methods 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 150000003431 steroids Chemical class 0.000 description 1
- QAHVHSLSRLSVGS-UHFFFAOYSA-N sulfamoyl chloride Chemical compound NS(Cl)(=O)=O QAHVHSLSRLSVGS-UHFFFAOYSA-N 0.000 description 1
- 239000000375 suspending agent Substances 0.000 description 1
- 239000006188 syrup Substances 0.000 description 1
- 235000020357 syrup Nutrition 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- CZDYPVPMEAXLPK-UHFFFAOYSA-N tetramethylsilane Chemical compound C[Si](C)(C)C CZDYPVPMEAXLPK-UHFFFAOYSA-N 0.000 description 1
- 238000004809 thin layer chromatography Methods 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
- C07D209/42—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pain & Pain Management (AREA)
- Public Health (AREA)
- Rheumatology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Indole Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US75320085A | 1985-07-09 | 1985-07-09 | |
| US82129686A | 1986-01-22 | 1986-01-22 | |
| US06/825,017 US4678802A (en) | 1985-07-09 | 1986-01-31 | 1-acylcarbamoyloxindole-3-carboxamides as antiinflammatory agents |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO862750D0 NO862750D0 (no) | 1986-07-08 |
| NO862750L true NO862750L (no) | 1987-01-12 |
Family
ID=27419443
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO862750A NO862750L (no) | 1985-07-09 | 1986-07-08 | Fremgangsmaate for fremstilling av farmakologisk aktive oksindol-derivater. |
Country Status (19)
| Country | Link |
|---|---|
| EP (1) | EP0208510B1 (zh) |
| JP (1) | JPH0610193B2 (zh) |
| CN (1) | CN86105309A (zh) |
| AT (1) | ATE67185T1 (zh) |
| AU (1) | AU566065B2 (zh) |
| CA (1) | CA1286663C (zh) |
| DE (1) | DE3681358D1 (zh) |
| DK (1) | DK324286A (zh) |
| ES (2) | ES2001855A6 (zh) |
| FI (1) | FI862882A (zh) |
| GR (1) | GR861760B (zh) |
| HU (2) | HUT41386A (zh) |
| IE (1) | IE58566B1 (zh) |
| IL (1) | IL79356A (zh) |
| NO (1) | NO862750L (zh) |
| NZ (1) | NZ216788A (zh) |
| PH (1) | PH22641A (zh) |
| PT (1) | PT82931B (zh) |
| YU (2) | YU45346B (zh) |
Families Citing this family (28)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IE68593B1 (en) | 1989-12-06 | 1996-06-26 | Sanofi Sa | Heterocyclic substituted acylaminothiazoles their preparation and pharmaceutical compositions containing them |
| FR2655344B1 (fr) * | 1989-12-06 | 1992-04-03 | Sanofi Sa | Derives heterocycliques d'acylaminothiazoles, leur preparation et compositions pharmaceutiques en contenant. |
| WO1991009598A1 (en) * | 1990-01-05 | 1991-07-11 | Pfizer Inc. | Azaoxindole derivatives |
| FR2677356B1 (fr) * | 1991-06-05 | 1995-03-17 | Sanofi Sa | Derives heterocycliques d'acylamino-2 thiazoles-5 substitues, leur preparation et compositions pharmaceutiques en contenant. |
| JPH08288983A (ja) * | 1995-04-17 | 1996-11-01 | Tokyo Tsuuki:Kk | リンガ回路 |
| US6369056B1 (en) | 1999-05-04 | 2002-04-09 | American Home Products Corporation | Cyclic urea and cyclic amide derivatives |
| US6509334B1 (en) | 1999-05-04 | 2003-01-21 | American Home Products Corporation | Cyclocarbamate derivatives as progesterone receptor modulators |
| US6319912B1 (en) | 1999-05-04 | 2001-11-20 | American Home Products Corporation | Cyclic regimens using 2,1-benzisothiazoline 2,2-dioxides |
| US6355648B1 (en) * | 1999-05-04 | 2002-03-12 | American Home Products Corporation | Thio-oxindole derivatives |
| US6380178B1 (en) | 1999-05-04 | 2002-04-30 | American Home Products Corporation | Cyclic regimens using cyclocarbamate and cyclic amide derivatives |
| US6462032B1 (en) | 1999-05-04 | 2002-10-08 | Wyeth | Cyclic regimens utilizing indoline derivatives |
| US6498154B1 (en) | 1999-05-04 | 2002-12-24 | Wyeth | Cyclic regimens using quinazolinone and benzoxazine derivatives |
| US6399593B1 (en) | 1999-05-04 | 2002-06-04 | Wyeth | Cyclic regimens using cyclic urea and cyclic amide derivatives |
| US6391907B1 (en) | 1999-05-04 | 2002-05-21 | American Home Products Corporation | Indoline derivatives |
| US6444668B1 (en) | 1999-05-04 | 2002-09-03 | Wyeth | Combination regimens using progesterone receptor modulators |
| US6358948B1 (en) | 1999-05-04 | 2002-03-19 | American Home Products Corporation | Quinazolinone and benzoxazine derivatives as progesterone receptor modulators |
| US6358947B1 (en) | 1999-05-04 | 2002-03-19 | American Home Products Corporation | Tetracyclic progesterone receptor modulator compounds and methods |
| US6306851B1 (en) | 1999-05-04 | 2001-10-23 | American Home Products Corporation | Cyclocarbamate and cyclic amide derivatives |
| US6407101B1 (en) | 1999-05-04 | 2002-06-18 | American Home Products Corporation | Cyanopyrroles |
| US6329416B1 (en) | 1999-05-04 | 2001-12-11 | American Home Products Corporation | Combination regimens using 3,3-substituted indoline derivatives |
| US6423699B1 (en) | 1999-05-04 | 2002-07-23 | American Home Products Corporation | Combination therapies using benzimidazolones |
| US6380235B1 (en) | 1999-05-04 | 2002-04-30 | American Home Products Corporation | Benzimidazolones and analogues |
| US6417214B1 (en) | 1999-05-04 | 2002-07-09 | Wyeth | 3,3-substituted indoline derivatives |
| US6339098B1 (en) | 1999-05-04 | 2002-01-15 | American Home Products Corporation | 2,1-benzisothiazoline 2,2-dioxides |
| UA73119C2 (en) | 2000-04-19 | 2005-06-15 | American Home Products Corpoir | Derivatives of cyclic thiocarbamates, pharmaceutical composition including noted derivatives of cyclic thiocarbamates and active ingredients of medicines as modulators of progesterone receptors |
| CA2416397A1 (en) | 2000-07-19 | 2003-01-16 | Ube Industries, Ltd. | Process for producing 5-fluorooxyindole and for producing intermediate therefor |
| JP2004529110A (ja) | 2001-03-06 | 2004-09-24 | アストラゼネカ アクチボラグ | 脈管損傷活性を有するインドール誘導体 |
| JP4770826B2 (ja) * | 2007-11-22 | 2011-09-14 | 大日本印刷株式会社 | ２−オキシインドール誘導体の製造法 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3749731A (en) * | 1971-07-08 | 1973-07-31 | Warner Lambert Co | 2-oxo-n-(2-thiazolyl)-3-indoline-carboxamide |
| US3882236A (en) | 1973-12-26 | 1975-05-06 | Lilly Co Eli | Pharmaceutical compositions containing substituted 2-oxo-indolines and the use thereof to treat anxiety and tension |
| US4556672A (en) * | 1984-03-19 | 1985-12-03 | Pfizer Inc. | 3-Substituted 2-oxindole-1-carboxamides as analgesic and anti-inflammatory agents |
| US4690943A (en) * | 1984-09-19 | 1987-09-01 | Pfizer Inc. | Analgesic and antiinflammatory 1,3-diacyl-2-oxindole compounds |
-
1986
- 1986-07-02 EP EP86305144A patent/EP0208510B1/en not_active Expired - Lifetime
- 1986-07-02 DE DE8686305144T patent/DE3681358D1/de not_active Expired - Fee Related
- 1986-07-02 AT AT86305144T patent/ATE67185T1/de not_active IP Right Cessation
- 1986-07-07 PT PT82931A patent/PT82931B/pt not_active IP Right Cessation
- 1986-07-07 GR GR861760A patent/GR861760B/el unknown
- 1986-07-07 CA CA000513184A patent/CA1286663C/en not_active Expired - Fee Related
- 1986-07-08 FI FI862882A patent/FI862882A/fi not_active Application Discontinuation
- 1986-07-08 PH PH33993A patent/PH22641A/en unknown
- 1986-07-08 HU HU862844A patent/HUT41386A/hu not_active IP Right Cessation
- 1986-07-08 HU HU862844D patent/HU198015A/hu not_active IP Right Cessation
- 1986-07-08 YU YU1203/86A patent/YU45346B/xx unknown
- 1986-07-08 DK DK324286A patent/DK324286A/da not_active Application Discontinuation
- 1986-07-08 AU AU59847/86A patent/AU566065B2/en not_active Ceased
- 1986-07-08 ES ES8600191A patent/ES2001855A6/es not_active Expired
- 1986-07-08 JP JP61160675A patent/JPH0610193B2/ja not_active Expired - Lifetime
- 1986-07-08 IL IL79356A patent/IL79356A/xx not_active IP Right Cessation
- 1986-07-08 NZ NZ216788A patent/NZ216788A/xx unknown
- 1986-07-08 IE IE183386A patent/IE58566B1/en not_active IP Right Cessation
- 1986-07-08 NO NO862750A patent/NO862750L/no unknown
- 1986-07-09 CN CN198686105309A patent/CN86105309A/zh active Pending
-
1987
- 1987-06-18 YU YU01144/87A patent/YU114487A/xx unknown
- 1987-12-15 ES ES8703589A patent/ES2009227A6/es not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| YU120386A (en) | 1988-02-29 |
| DK324286D0 (da) | 1986-07-08 |
| IE58566B1 (en) | 1993-10-06 |
| IL79356A (en) | 1990-03-19 |
| IL79356A0 (en) | 1986-10-31 |
| YU114487A (en) | 1988-02-29 |
| PT82931B (pt) | 1989-01-30 |
| DK324286A (da) | 1987-01-10 |
| AU566065B2 (en) | 1987-10-08 |
| NZ216788A (en) | 1988-10-28 |
| ES2009227A6 (es) | 1989-09-16 |
| PH22641A (en) | 1988-10-28 |
| CA1286663C (en) | 1991-07-23 |
| ATE67185T1 (de) | 1991-09-15 |
| PT82931A (en) | 1986-08-01 |
| ES2001855A6 (es) | 1988-07-01 |
| FI862882A0 (fi) | 1986-07-08 |
| GR861760B (en) | 1986-11-10 |
| YU45346B (en) | 1992-05-28 |
| DE3681358D1 (de) | 1991-10-17 |
| IE861833L (en) | 1987-01-09 |
| CN86105309A (zh) | 1987-01-14 |
| EP0208510A2 (en) | 1987-01-14 |
| AU5984786A (en) | 1987-04-09 |
| JPH0610193B2 (ja) | 1994-02-09 |
| NO862750D0 (no) | 1986-07-08 |
| JPS6226269A (ja) | 1987-02-04 |
| EP0208510B1 (en) | 1991-09-11 |
| HU198015A (en) | 1989-07-28 |
| FI862882A (fi) | 1987-01-10 |
| EP0208510A3 (en) | 1988-03-02 |
| HUT41386A (en) | 1987-04-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO862750L (no) | Fremgangsmaate for fremstilling av farmakologisk aktive oksindol-derivater. | |
| EP0164860B1 (en) | N,3-disubstituted 2-oxindole-1-carboxamides as analgesic and antiinflammatory agents | |
| EP0156603B1 (en) | 3-substituted 2-oxindole-1-carboxamides as analgesic and anti-inflammatory agents | |
| EP0175551B1 (en) | Analgesic and antiinflammatory 1,3-diacyl-2-oxindole compounds | |
| CA2146961C (en) | Heterobicyclic sulfonamide and sulfonic ester derivatives | |
| US4721712A (en) | 1,3-disubstituted 2-oxindoles as analgesic and anti-inflammatory agents | |
| US4658037A (en) | Intermediates for 1,3-disubstituted 2-oxindoles as analgesic and antiinflammatory agents | |
| US4678802A (en) | 1-acylcarbamoyloxindole-3-carboxamides as antiinflammatory agents | |
| NO340511B1 (no) | Aminoarylsulfonamidderivater som funksjonelle 5-ht6 ligander | |
| EP2121602B1 (en) | 4-(heterocyclyl)alkyl-n-(arylsulfonyl) indole compounds and their use as 5-ht6 ligands | |
| US4791129A (en) | 1,3-dicarboxamidooxindoles as analgesic and antiinflammatory agents | |
| EP0153818B1 (en) | 1,3-disubstituted 2-oxindoles as analgesic and anti-inflammatory agents | |
| EP0155828B1 (en) | Process for making 2-oxindole-1-carboxamides and intermediates therefor | |
| WO2007138611A1 (en) | 3-(heterocyclyl)-n-(arylsulfonyl)indole derivatives as functional 5-ht6 ligands | |
| US4808601A (en) | Analgesic and antiinflammatory 1,3-diacyl-2-oxindole compounds | |
| NO742929L (zh) | ||
| US4730004A (en) | Analgesic and anti-inflammatory 1-acyl-2-oxindole-3-carboxamides | |
| KR880002272B1 (ko) | 1-치환된 옥신돌-3-카복사마이드의 제조방법 | |
| US4791131A (en) | Analgesic and antiinflammatory 1-acyl-2-oxindole-3-carboxamides | |
| NO148490B (no) | Analogifremgangsmaate for fremstilling av medisinsk virksomme 1,2-tiazino(5,6-b)indoler | |
| NO163132B (no) | Analogifremgangsmaate for fremstilling av en terapeutisk aktiv 2-oksindol-1-karboksamid-forbindelse og mellomproduktfor fremstilling derav. | |
| HU194165B (en) | Process for preparing 1,3-oxyacyl-2-oxindole derivatives | |
| CA1289556C (en) | 1- or 3-monosubstituted 2-oxindole compound intermediates useful for the production of analgesic and anti-inflammatory agents | |
| IE850288L (en) | Analgesic oxindoles. | |
| NO165798B (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive 1,3-disubstituerte 2-oksindol-derivater. |